image
Capricor Therapeutics, Inc. CAPR
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 18.61
0.649 %
$ 846 M
Market Cap
-20.91
P/E
CASH FLOW STATEMENT
-25.6 M OPERATING CASH FLOW
-520.61%
Growth Rates
1Year -520.61%
3Years -36.54%
5Years -13.05%
7Years -7.13%
10Years -15.34%
5.11 M INVESTING CASH FLOW
114.56%
Growth Rates
1Year 114.56%
3Years -2.07%
5Years 1.80%
7Years 16.90%
10Years 3.06%
25.6 M FINANCING CASH FLOW
424.84%
Growth Rates
1Year 424.84%
3Years -8.49%
5Years 30.14%
7Years 4.63%
10Years 20.62%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Capricor Therapeutics, Inc.
image
Net Income -22.3 M
Depreciation & Amortization 1.07 M
Capital Expenditures -2.05 M
Stock-Based Compensation 7.39 M
Change in Working Capital -11.8 M
Others -3.27 M
Free Cash Flow -27.6 M

Cash Flow

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012 Dec-2011 Dec-2010 Dec-2009 Dec-2008 Dec-2007 Dec-2006 Dec-2005 Dec-2004 Dec-2003 Dec-2002 Dec-2001 Dec-2000 Dec-1999
OPERATING CASH FLOW
Net Income (22.3) (29.0) (20.0) (13.7) (7.6) (15.2) 2.4 (18.8) (12.9) (6.2) (8.9) (1.9) (4.9) (6.0) (7.9) (13.1) (10.3) 61.4 K 18.9 K 18.1 K 16.2 K 15.6 K 22.3 K 36.5 K 200
Depreciation & Amortization 1.1 0.5 0.2 0.1 0.2 0.2 0.1 0.1 0.1 41.9 K 26.9 K 6.26 K 7.51 K 12.9 K 0.2 0.1 27 K 0 0 0 0 0 83 200 200
Deferred Income Tax 0 0 (0.3) (0.3) 0 0 0 (2.0) (1.6) (0.5) (0.3) (0.9) 4.9 0 (2.2) (3.0) (3.1) 0 0 0 0 0 0 0 0
Stock Based Compensation 7.4 4.5 3.0 2.0 0.7 1.7 1.7 2.0 1.6 0.5 0.3 0.3 0.8 1.1 2.2 3.0 3.1 0 0 0 0 0 0 0 0
Other Operating Activities 18.2 K 0.2 0.1 0.3 2.72 K 2.3 (15.7) 3.5 1.6 0.5 2.2 0.3 (4.9) 0.1 2.2 3.0 4.0 4.2 K 0 0 0 0 0 15.2 K 900
Change in Working Capital (11.8) 28.7 0.2 1.5 55.3 K (0.6) (2.9) (0.6) 0.4 6.6 0.5 64.1 K (0.6) 0.5 (0.4) (0.7) 0.9 1.56 K 1.07 K 2.6 K 4.66 K 1.27 K 9.2 K 14.2 K 900
Cash From Operations (25.6) 4.9 (16.8) (10.1) (6.8) (13.9) (14.2) (15.8) (10.8) 1.0 (6.1) (2.2) (4.6) (4.3) (5.8) (10.6) (5.4) 55.6 K 17.8 K 15.5 K 20.8 K 14.3 K 13 K 37.3 K 900
INVESTING CASH FLOW
Capital Expenditures (2.0) (3.4) (1.2) (0.5) 0 (0.3) 32.2 K (0.2) (0.2) (0.2) (0.1) 13.4 K 1.99 K 2.2 K 36.7 K 92.6 K (0.3) 0 0 0 0 0 0 0 0
Other Items 7.2 (31.7) 0 6.0 (3.0) 5.0 5.0 (5.0) (8.0) 0.3 3.9 (4.3) 0 0 2.5 K 0 0 0 0 0 0 0 0 0 0
Cash From Investing Activities 5.1 (35.1) (1.2) 5.4 (3.0) 4.7 5.0 (5.2) (8.1) 0.1 3.8 (4.3) 1.99 K 2.2 K 34.2 K 92.6 K (0.3) 0 0 0 0 0 0 0 0
FINANCING CASH FLOW
Common Stock Repurchased 0 0 0 0 193 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Total Debt Repaid 0 0 0 0.3 0 0 0.5 4.8 0 5.2 3.9 0 0 0 0 0 0 4.0 0 0 29.3 K 7.66 K 0 0 0
Dividends Paid 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Financing Activities 64.6 K 70.3 K 50.6 K 5.7 3.22 K 0.1 6.64 K 14 K 45.5 K 4.83 K 0 5.0 13.7 K 6.21 K 0.2 0 0 0 17.4 K 15 K 7.43 K 6.53 K 0 0 0
Cash From Financing Activities 25.6 4.9 20.2 33.4 9.2 6.9 11.6 18.6 16.5 5.2 3.9 1.2 2.3 4.5 3.5 0 19.9 55.3 K 17.4 K 15 K 21.9 K 14.2 K 0 50.5 K 0
CHANGE IN CASH
Net Change In Cash 5.1 (25.3) 2.2 28.8 (0.6) (2.3) 2.3 (2.4) (2.5) 6.3 1.6 (1.0) (2.3) 0.2 (2.3) (10.7) 14.2 0 354 444 1.05 K 131 13 K 13.2 K 900
FREE CASH FLOW
Free Cash Flow (27.6) 1.6 (18.0) (10.6) (6.8) (14.2) (14.3) (16.0) (11.0) 0.8 (6.3) (2.2) (4.7) (4.3) (5.8) (10.7) (5.7) 55.6 K 17.8 K 15.5 K 20.8 K 14.3 K 13 K 37.3 K 900